Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability
Braz. j. med. biol. res; 49 (6), 2016
New generation antidepressant therapies, including serotonin-norepinephrine reuptake inhibitor (SNRIs), were introduced in the late 1980s; however, few comprehensive studies have compared the benefits and risks of various contemporary treatments for major depressive disorder (MDD) in young patients. A co...
Antidepresivos/uso terapéutico, Ciclopropanos/uso terapéutico, Trastorno Depresivo Mayor/tratamiento farmacológico, Succinato de Desvenlafaxina/uso terapéutico, Clorhidrato de Duloxetina/uso terapéutico, Milnaciprán, Placebos/uso terapéutico, Ensayos Clínicos Controlados Aleatorios como Asunto, Inhibidores de Captación de Serotonina y Norepinefrina/uso terapéutico